The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inhibitors

Terapevticheskii Arkhiv

Volumn 86, Issue 1, 2014, Pages 83-88

  Romantsov, M G ^a   Ershov, F I ^b   Kovalenko, A L ^c   Belova, O G ^d  

^a NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^b GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

^c Institute of Toxicology   (United States)

^d IMMANUEL KANT BALTIC FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Acute respiratory viral infections; Brucellosis; Cycloferon; Endometrial hyperplastic processes; Influenza; Interferon; Interferon inductors; Tuberculosis; Viral and bacterial infections; Viral hepatitis

Indexed keywords

10-CARBOXYMETHYL-9-ACRIDANONE; ACRIDINE DERIVATIVE; CRIDANIMOD; INTERFERON; INTERFERON INDUCING AGENT;

ANIMAL; BIOSYNTHESIS; HUMAN; INFECTION; METABOLISM; REVIEW;

ACRIDINES; ANIMALS; HUMANS; INFECTION; INTERFERON INDUCERS; INTERFERONS;

EID: 84899133308     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (3)

1. Maier W., Baumert A., Schumann B. et al. Synthesis of 1, 3-dihydroxy-N-methylacridone and its conversion to rutacridone by cell-free extracts of Ruta graveolens cell cultures. Phytochem 1992; 32 (3): 691-698.
2. Caviar T., Deimling T., Ablasser A. et al. Species-specific detection of the antiviral small-molecule compound CMA by STING. EMBO J 2013; 32 (10): 1440-1450.
3. Krishnegowda G., Thimmaiah P., Hegde R. et al. Synthesis and chemical characterization of 2-methoxy-N10-substitutedacridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells. Bioorg Med Chem 2002; 10: 2367-2380.